KIRKLAND, WA and WASHINGTON, DC--(Marketwire - October 10, 2008) - 20th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium -- Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), today announced that the company will present final data from Pathway's pivotal, multi-center European clinical trial for its first-generation device, the Pathway PV™ Atherectomy System, as well as interim study data for its next-generation device, at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium (TCT 2008), sponsored by the Cardiovascular Research Foundation (CRF). The data, presented by Dr. Thomas Zeller of Bad Krozingen in Germany and co-principal investigator of Pathway's clinical trials, demonstrate the safety and efficacy of Pathway's atherectomy catheter for the treatment of PAD in the lower limbs. In addition, Pathway will host a Breakfast Symposium providing an overview of the company's innovative technology. TCT 2008 takes place October 12-17, 2008 at the Washington Convention Center in Washington, D.C.
